1. Apoptosis Metabolic Enzyme/Protease Cell Cycle/DNA Damage
  2. Apoptosis Caspase HSP Early 2 Factor (E2F) DNA/RNA Synthesis
  3. Ly101-4B

Ly101-4B 是一种凋亡 (apoptosis) 诱导剂和多靶点抑制剂,具有抗增殖、抗肿瘤与细胞毒性效应。Ly101-4B 可降低 HSF1 表达、抑制 microRNA-214 合成,并下调 HSP27、HSP70、HSP90 表达,同时抑制 E2F 依赖性转录活性并下调其靶基因。Ly101-4B 通过减少 DNA 合成、抑制细胞周期与 G1/S 期转换等方式诱导 caspase 3/7 介导的凋亡,不影响 RNA 合成或引发坏死。Ly101-4B 对不同基因型及 E2F 依赖程度的胰腺导管腺癌细胞具有选择性。Ly101-4B 可用于上皮性卵巢癌和胰腺导管腺癌的相关研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Ly101-4B

Ly101-4B Chemical Structure

CAS No. : 1415728-94-7

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Ly101-4B is an apoptosis inducer and multi-target inhibitor with antiproliferative, antitumor and cycytotoxic effects. Ly101-4B reduces HSF1 expression, inhibits microRNA-214 synthesis, downregulates HSP27, HSP70 and HSP90 expression, while suppressing E2F-dependent transcriptional activity and downregulating its target genes. Ly101-4B induces caspase 3/7-mediated apoptosis by reducing DNA synthesis, inhibiting the cell cycle and G1/S phase transition, without affecting RNA synthesis or inducing necrosis. Ly101-4B is selective for pancreatic ductal adenocarcinoma cells with different genotypes and varying degrees of E2F dependence. Ly101-4B can be used in research related to epithelial ovarian cancer and pancreatic ductal adenocarcinoma[1][2][3].

IC50 & Target

Caspase-3

 

Caspase-7

 

HSP70

 

HSP90

 

HSF1

 

体外研究
(In Vitro)

Ly101-4B (20-100 μM;24-48 h) 可抑制人上皮性顺铂耐药卵巢癌细胞 SKOV3 的增殖、诱导其凋亡,并下调该细胞中 HSF1、HSP27、HSP70 和 HSP90 的表达[1]
Ly101-4b (20-100 μM;48 小时) 可降低原代 Nupr1 缺陷型和 Nupr1 wt;KIC 胰腺癌细胞的活力,在 100 μM 浓度下存在显著的差异效应[2]
Ly101-4B (1-25 μM;12-72 h) 在E2F 依赖性报告基因载体的荧光素酶活性验证实验中,可抑制 MiaPaCa2 细胞中的 E2F 活性[3]
Ly101-4B (25 μM;12-72 h) 可降低 MiaPaCa2 细胞的活力,诱导 caspase 3/7 介导的细胞凋亡,并抑制 DNA 合成,但不影响 RNA 合成或引发细胞坏死[3]
Ly101-4B 对 E2F 高表达原代 PDAC 细胞 (CRCM93、CRCM08、CRCM17) 的效力优于 E2F 低表达原代 PDAC 细胞 (CRCM10、CRCM12、CRCM110、CRCM92),其 72 h IC50值更低 (19.4 μM vs 44.1 μM)[3]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay[1]

Cell Line: SKOV3 human epithelial cisplatin-resistant ovarian cancer cells
Concentration: 60 μM (HSF1 protein depletion); 20-100 μM (cell viability assessment)
Incubation Time: 48 h (HSF1 protein depletion, cell viability assessment); 24 h (HSF1 mRNA measurement)
Result: Efficiently inhibited cell proliferation with greater efficiency than cisplatin. Decreased HSF1 mRNA levels after 24 h of treatment. Considerably depleted HSF1 protein expression after 48 h of treatment. Increased the percentage of early apoptotic cells from 5.0% to 19.0%. Accumulated the cleaved form of caspase9 (p35 segment). Considerably decreased protein expression of HSP27, HSP70, and HSP90.

Cell Viability Assay[2]

Cell Line: primary Nupr1-deficient pancreatic cancer cells, primary Nupr1wt;KIC pancreatic cancer cells
Concentration: 20, 50, 100 μM
Incubation Time: 48 h
Result: Induced a reduction in cell viability in both Nupr1-deficient and Nupr1wt; KIC cells starting from 20 μM. Showed activity comparable to that of gemcitabine from 50 μM. Observed a significant differential response at 100 μM.
体内研究
(In Vivo)

Ly101-4B (100 mg/kg;腹腔注射;每周 2 次;持续 4 周) 在雌性裸鼠(无胸腺小鼠)中,可通过下调 HSF1 和 miR-214 显著抑制卵巢肿瘤的体内生长,且无不良反应[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: BALB/c-nu/nu (female, 4-week old)[1]
Dosage: 100 mg/kg
Administration: i.p.; twice a week; 4 weeks
Result: Significantly retarded tumor growth compared to control;
Detected few Ki-67-positive cells in treated tumors;
Sharply decreased HSF1-positive cells and staining intensity;
Depleted HSF1 mRNA and miR-214 levels in treated tumors.
分子量

442.51

Formula

C23H30N4O5

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Ly101-4B
目录号:
HY-164184
需求量: